President Trump’s approval rating has dipped slightly in new polling just more than two months into his second term. A Harvard CAPS/Harris poll found 49 percent of registered voters approved of ...

President Trump’s approval rating has ticked up in his second term, driven by higher support from Republicans and particularly men and conservatives, according to a new poll from Gallup.

Our Data and News subscriptions grant you access to our extensive databases for Commercial and Business Aviation. You can read our Exclusive News Stories, look up Aircraft Operators, analyse global ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. President Donald Trump speaks at the National ...

The implantable vascular conduit, which is indicated for arterial injury, won FDA approval in December 2024. Symvess is intended for use in both hospitals and for military use. Although repairing ...

MANILA, Philippines — Top Line Business Development Corp. has obtained final regulatory approval for its maiden share sale, paving the way for the country’s first initial public offering (IPO ...

Presidential approval ratings provide a glimpse of how Americans really feel on any given day, often times driven by his handling of the issues at hand. Here's how Trump is polling after his first ...

While Trump's net approval ratings came out of the gates higher than in 2017, though still lower than those of any other president in modern history, recent polls show public sentiment more split ...

Eliminating it in its entirety would require action from Congress. Has this news impacted Trump's approval rating? Here's what to know. U.S. President Donald Trump reacts as he meets NATO ...

President Trump's approval rating hovers around 47% according to various polls. Trump's approval rating remains largely partisan, with a significant gap between Democrats and Republicans.

The Food and Drug Administration on Thursday approved an Alnylam Pharmaceuticals medicine for a serious heart condition, a decision that should help the biotechnology firm secure its position as one ...

Andrew Stanton is a Newsweek weekend reporter based in Maine. His role is reporting on U.S. politics and social issues. Andrew joined Newsweek in 2021 from The Boston Globe. He is a graduate of ...